Mivazerol

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMivazerol
Drug Alias Namemivazerol米伐折醇米伐西醇mivazerolum米伐泽醇 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUcb
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb
Active IndicationsN/A
Inactive IndicationsMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksWikipedia